BiomX (PHGE) Other Working Capital Changes (2018 - 2026)
BiomX (PHGE) posted Other Working Capital Changes of -$119000.0 for Q4 2025, down 383.33% sequentially from $42000.0 in Q3 2025, and down 123.94% YoY from $497000.0 in Q4 2024.
BiomX (PHGE) Other Working Capital Changes (2018 - 2026) Analysis & Trends
BiomX has reported Other Working Capital Changes for 5 years, with the latest figure at -$119000.0 in Q4 2025.
- Quarterly Other Working Capital Changes fell 123.94% year-over-year to -$119000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$74000.0 (down 104.44% YoY) and the FY2025 annual result came in at -$74000.0, down 123.42% from the prior year.
- Other Working Capital Changes slipped to -$119000.0 in Q4 2025 per PHGE's latest filing, from $42000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.6 million in Q4 2022 and troughed at -$1.2 million in Q1 2022.
- A 5-year average of -$180375.0 and a median of -$366500.0 in 2025 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 5430.77% in 2024, then tumbled 123.94% in 2025.
- Over 5 years, Other Working Capital Changes stood at $179000.0 in 2021, then soared by 317.32% to $747000.0 in 2022, then sank by 104.42% to -$33000.0 in 2023, then surged by 1606.06% to $497000.0 in 2024, then tumbled by 123.94% to -$119000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$119000.0, $42000.0, and -$3000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | BiomX | 362,449.94 | -805,550.06 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.41 Mn |
| Mar 31, 2026 | 1.41 Mn |
| Mar 31, 2026 | 1.41 Mn |
| Dec 31, 2025 | -491,000.00 |
| Dec 31, 2025 | -491,000.00 |
| Dec 31, 2025 | -491,000.00 |
| Sep 30, 2025 | -656,000.00 |
| Sep 30, 2025 | -656,000.00 |
| Sep 30, 2025 | -656,000.00 |
| Jun 30, 2025 | -854,000.00 |
| Jun 30, 2025 | -854,000.00 |
| Jun 30, 2025 | -854,000.00 |
| Mar 31, 2025 | -242,000.00 |
| Mar 31, 2025 | -242,000.00 |
| Mar 31, 2025 | -242,000.00 |
| Dec 31, 2024 | -1.06 Mn |
| Dec 31, 2024 | -1.06 Mn |
| Dec 31, 2024 | -1.06 Mn |
| Sep 30, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.02 Mn |